AL
MYGN icon

AJO LP’s Myriad Genetics MYGN Stock Holding History

AJO LP’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-255,334
Closed -$4.9M – 614
2017
Q1 		$4.9M Buy
255,334
+28,017
+12% +$496K 0.02% 287
2016
Q4 		$3.79M Sell
227,317
-200,095
-47% -$3.62M 0.02% 297
2016
Q3 		$8.8M Sell
427,412
-55,921
-12% -$1.42M 0.04% 237
2016
Q2 		$14.8M Sell
483,333
-85,979
-15% -$2.99M 0.07% 188
2016
Q1 		$21.3M Buy
569,312
+46,586
+9% +$1.76M 0.09% 171
2015
Q4 		$22.6M Buy
522,726
+48,245
+10% +$2.04M 0.1% 167
2015
Q3 		$17.8M Buy
474,481
+230,671
+95% +$8.19M 0.08% 174
2015
Q2 		$8.29M Buy
243,810
+3,780
+2% +$129K 0.04% 266
2015
Q1 		$8.5M Sell
240,030
-157,540
-40% -$5.64M 0.04% 244
2014
Q4 		$13.5M Buy
397,570
+167,120
+73% +$5.93M 0.06% 191
2014
Q3 		$8.89M Buy
230,450
+9,550
+4% +$356K 0.04% 210
2014
Q2 		$8.6M Sell
220,900
-274,900
-55% -$10.2M 0.04% 227
2014
Q1 		$17M Sell
495,800
-150,500
-23% -$4.66M 0.07% 150
2013
Q4 		$13.6M Buy
646,300
+257,300
+66% +$6.51M 0.06% 176
2013
Q3 		$9.14M Sell
389,000
-320,100
-45% -$9.09M 0.04% 200
2013
Q2 		$19.1M Buy
+709,100
New +$20.6M 0.09% 143

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AJO LP's MYGN Position: Q2 2017 in Review

AJO LP sold out of Myriad Genetics (MYGN) in Q2 2017, closing a stake of 255,334 shares — an estimated $4.9M sold.

AJO LP first reported a position in MYGN in Q2 2013 and held it in 16 quarters. The position peaked at $22.6M in Q4 2015. 239 funds tracked by Wall St. Rank hold MYGN as of Q2 2017.

  • AJO LP reported no remaining Myriad Genetics position as of Q2 2017 after selling out during the quarter.
  • AJO LP sold 255,334 Myriad Genetics shares in Q2 2017, an estimated $4.9M.
  • AJO LP first reported a position in Myriad Genetics in Q2 2013 and held it in 16 quarters.
  • AJO LP's Myriad Genetics position peaked at $22.6M in Q4 2015.
  • 239 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2017.

Based on AJO LP's 13F filing for Q2 2017, filed 10 Aug 2017.